MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

Search

Integra LifeSciences Holdings Corp

Abierto

SectorSanidad

16.38 -1.15

Resumen

Variación precio

24h

Actual

Mínimo

16.14

Máximo

16.91

Métricas clave

By Trading Economics

Ingresos

30M

19M

Ventas

62M

443M

P/B

Media del Sector

63.02

57.333

BPA

0.97

Margen de beneficios

4.391

Empleados

4,396

EBITDA

40M

79M

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 Meses

+47.31% upside

Dividendos

By Dow Jones

Próximas Ganancias

5 may 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-819M

1.2B

Apertura anterior

17.53

Cierre anterior

16.38

Puntuación técnica

By Trading Central

Confianza

Strong Bullish Evidence

Integra LifeSciences Holdings Corp Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

6 may 2024, 16:47 UTC

Ganancias
Principales Movimientos del Mercado

Integra LifeSciences Shares Drop to Record Low on Unexpected Loss, Boston Facility Audit Findings

Comparación entre iguales

Cambio de precio

Integra LifeSciences Holdings Corp previsión

Precio Objetivo

By TipRanks

47.31% repunte

Estimación a 12 Meses

Media 24.6 USD  47.31%

Máximo 35 USD

Mínimo 19 USD

De acuerdo con 6 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Integra LifeSciences Holdings Corp Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

6 ratings

2

Comprar

2

Mantener

2

Vender

Puntuación técnica

By Trading Central

15.67 / 17.29Soporte y Resistencia

Corto Plazo

Strong Bullish Evidence

Medio plazo

Very Strong Bearish Evidence

Largo Plazo

Bearish Evidence

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Integra LifeSciences Holdings Corp

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.